Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 27 28 29 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Trinean–Sony: microfluidics disposables, 201404– supply OEM for DropSense96 spectrometer + Xpose Touch&Go sample QC analyzer by Sony DADC BioSciences 2014-04-01
Convergence Pharmaceuticals–Evotec: drug discovery services, 201403– collab €na pain drug r+d with Panion Ltd 2014-03-31
Convergence Pharmaceuticals–United Kingdom (govt): grant, 201403c– Biomedical Catalyst grant £2.4m to develop drug against novel GPCR pain target 2014-03-31
Singulex–Sony: microtitre plates, 201403– supply of customised detection vessels as microtitre plate for Sgx Clarity System by Sony DADC BioSciences 2014-03-31
Univ Oulu–Bruker Corp: mass spectrometer, 201403 supply existent UltrafleXtreme MALDI Tof/Tof listed on web site of MS Core Facility 2014-03-30
Anatech Instruments–Fortis Technologies: HPLC columns, 201403 distribution existent in South Africa by Anatech Instruments 2014-03-29
Dichrom–Fortis Technologies: HPLC columns, 201403 distribution existent in Germany by Dichrom 2014-03-29
Genmab–MAB Discovery: drug discovery services, 201403– collab €na generation of antibodies for multiple Genmab targets 2014-03-27
MAB Discovery–MC Services: public relations, 201403 service existent for MAB Discovery GmbH 2014-03-27
Singulex–Tecan: automated liquid handling, 201403– collab developm of Sgx Clarity System using Freedom EVO platform 2014-03-25
Bionamics–Evotec: investment, 201403 acquisition €na 100% against cash + future milestone payments 2014-03-24
Evotec–Reach Separations: chromatography, 201403– collab with Reach becoming technology partner providing small molecule chromatography 2014-03-19
Ipca Laboratories–Reach Separations: chromatography, 201403 collab existent offer custom separation services with Onyx Scientific 2014-03-19
Seltenerden Storkwitz–BRAIN: industrial biotechnology, 201403– collab expansion strategic partnership biotech extraction of rare earth metals 2014-03-19
Thermo Fisher–Harvard Univ: mass spectrometry, 201403– collab establ Center for Multiplexed Proteomics + develop methods + trainings w Prof Gygi 2014-03-19
Prionics–Thermo Fisher: investment, 201403 acquisition by Thermo Fisher 2014-03-17
Sysmex–Merck (DE): flow cytometry, 201404– collab research + licensing + co-developm agreem to use Amnis imaging flow cytometry for blood diagnostics 2014-03-17
Activaero–Vectura: investment, 201403 acquisition €130m with €45m cash upfront + €35m in Aug 2015 + €50m in shares 2014-03-13
Inotrem–BioMedPartners: investment, 201403 financing round Series A totalling €18m incl co-investor BioMedInvest II fund 2014-03-13
Inotrem–LCF Rothschild: investment, 201403 financing round Series A totalling €18m co-led by EdRIP + Sofinnova Partners 2014-03-13
Inotrem–MC Services: public relations, 201403 service existent for Inotrem SA 2014-03-13
Inotrem–SEVERAL: investment, 201403 financing round Series A €18m co-led by EdRIP + Sofinnova Partners 2014-03-13
Qiagen–SEVERAL: credit, 201403–2019 convertible notes $430m at 0.375% 2014-03-12
Qiagen–SEVERAL: credit, 201403–2021 convertible notes $300m at 0.875% to repay outstanding $291m notes due 2026 2014-03-12
Chemie.DE–Köhl et Feling: public relations, 201403 service existent for Chemie.DE Information Service GmbH 2014-03-11
Exosome Diagnostics–Arcus Ventures: investment, 201403 financing round Series B totalling $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Exosome Diagnostics–Forbion: investment, 201403 financing round Series B totalling $27m incl returning co-investors NGN Capital + Forbion 2014-03-11
Exosome Diagnostics–NGN Capital: investment, 201403 financing round Series B totalling $27m incl returning co-investors NGN Capital + Forbion 2014-03-11
Exosome Diagnostics–Qiagen: investment, 201403 financing round Series B totalling $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Exosome Diagnostics–SEVERAL: investment, 201403 financing round Series B $27m co-led by Qiagen + Arcus Ventures 2014-03-11
Glycotope–Eckert Wagniskapital: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–SEVERAL: investment, 201403 financing round €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Glycotope–Strüngmann Group: investment, 201403 financing round totalling €55m from Jossa Arznei GmbH + ELSA GmbH 2014-03-11
Biognosys–ETH Zürich: mass spectrometry s/w, 201403– collab testing of SpectroDive PRM s/w by FGCZ 2014-03-07
Immunexpress–Debiopharm: investment, 201403 financing round totalling $6m incl lead investor Debiopharm Diagnostics SA 2014-03-05
Immunexpress–SEVERAL: investment, 201403 financing round $6m led by Debiopharm 2014-03-05
4SC–Yorkville Group: credit, 201403 first tranche €500k convertible notes under up to €15m agreem from 2/14 w YA Global Master SPV Ltd 2014-03-04
Merus–Minapharm: GlymaxX technology, 201403– non-excl option + license agreem €na for use for bispecific cancer antibody from ProBioGen AG 2014-03-04
Agilent–Schauenburg: Unity-Air Server system, 201403 collab existent product integration of Unity into Agilent/Markes TD-GC-dual FID system 2014-03-01
BRAIN–Germany (govt): grant, 201403– BMBF funding for collab BRAIN + Selterden Storkwitz to develop bio-mining pilot plant for rare earth metals 2014-03-01
OPI (CH)–OSE Pharma: investment, 201403 acquisition of assets of OPI SA (Geneva) incl rights to Memopi technology 2014-03-01
Thermo Fisher–Schauenburg: Unity-Air Server system, 201403 collab existent product integration of Unity into Thermo Scientific/Markes TD-GC-MS system 2014-03-01
Gerstel–Spark Holland: dried blood spot technology, 201402– supply OEM incl FTD technology + DBS Autosampler for automated DBS systems of Gerstel 2014-02-28
Roche–Discuva: antibiotics, 201402– collab + license ww $16m upfront + $175m milestones per product + royalties r+d using SATIN technology 2014-02-28
Transgene–SEVERAL: investment, 201402 rights issue €45.5m with subscription rights €10/share 2014-02-28
microDimensions–High-Tech Gründerfonds: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
microDimensions–SEVERAL: investment, 201402 seed financing round with HTGF + Bayern Kapital + business angel Adriaan Hart de Ruijter 2014-02-27
BRAIN–BASF: food ingredients, 201402 acquisition of anti-bitter patents + utility patents from BASF by BRAIN 2014-02-25
Evolva–SEVERAL: investment, 201402–201403 private placement CHF42.5m with 27m+5.5m new shares CHF1.37/share 2014-02-25
Sysmex–Roche: PCR technology, 201402– license ww non-excl for emPCR patent portfolio to Sysmex Inostics GmbH 2014-02-21
Amal Therapeutics–Boehringer: investment, 201402 seed funding round from Boehringer Ingelheim Venture Fund + HTGF 2014-02-20
Amal Therapeutics–High-Tech Gründerfonds: investment, 201402 seed funding round from Boehringer Ingelheim Venture Fund + HTGF 2014-02-20
Amal Therapeutics–SEVERAL: investment, 201402 seed funding round from Boehringer Ingelheim Venture Fund + HTGF 2014-02-20
Proteros–MC Services: public relations, 201402 service existent for Proteros Biostructures GmbH 2014-02-20
Centogene–OMERS (CA): investment, 201402 acquisition of Centogene’s Canadian business by LifeLabs 2014-02-19
Novimmune–SEVERAL: investment, 201402 financing round Series B CHF60m led by Rosetta Capital Ltd 2014-02-18
Synaffix–SEVERAL: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital 2014-02-18
Advanced Accelerator Applications–SEVERAL: investment, 201402 financing round €41m capital increase led by HBM Healthcare w €20m 2014-02-17
CoStim Pharmaceuticals–Novartis: investment, 201402 acquisition €na 2014-02-17
Horizon Discovery–Sirion Biotech: genomic technology, 201402– supply to + distribution of RANiONE based services + reagents by Horizon 2014-02-17
4SC–Yorkville Group: credit, 201402– up to nominally €15m convertible notes to be purchased until 12/16 by YA Global Master SPV Ltd 2014-02-12
Coramaze Technologies–High-Tech Gründerfonds: investment, 201402 seed funding round totalling €1m co-led by HTGF + Seed Capital Dortmund 2014-02-12
Coramaze Technologies–SEVERAL: investment, 201402 seed funding round €1m co-led by HTGF + Seed Capital Dortmund 2014-02-12
Horizon Discovery–Haplogen: cell lines, 201402– distribution ww of cell lines + related products by Horizon 2014-02-12
MyoPowers–Truffle Capital: investment, 201402 existent investment listed on Truffle web site 2014-02-12
Symetis–Truffle Capital: investment, 201402 existent investment listed on Truffle web site 2014-02-12
Insilico Biotechnology–Pharmacelsus: drug development services, 201402– collab offering joint services for preclinical characterisation of APIs 2014-02-10
L’Oréal–Evolva: biosynthetic production technology, 201402– collab developm yeast fermentation technology to produce cosmetic ingredients 2014-02-10
Werum–Körber: investment, 201402– acquisition of newly formed Werum IT Solutions AG by Körber Medipak 2014-02-10
Anergis–SEVERAL: investment, 201402 financing round CHF8m co-led by Sunstone Capital + BioMedInvest + Renaissance PME/Vinci Capital 2014-02-05
Mologen–SEVERAL: investment, 201402 capital increase €15.7m gross proceeds 1,541,244 shares €10.2/share 2014-02-05
Agenus–SEVERAL: invesment, 201402 public offering $60m net $56m 19.335m+2.9m shares $2.7/share 2014-02-04
Bayer–Helmholtz: cancer research, 201402– collab strategic alliance 5y with DKFZ planned combined investment of up to €30m 2014-02-04
General Electric–Definiens: image analysis s/w, 201402– supply automated solutions to Clariant Diagnostic Services for clinical breast cancer testing 2014-02-03
LABiTec–HUMAN Diagnostics Worldwide: investment, 201401 acquisition €na of LAbor BioMedical Technologies GmbH 2014-01-30
Danaher–Univ Münster: mass spectrometry, 201401 collab developm LC/MS/MS method for halal food testing of meat with Institute for Food Chemistry 2014-01-28
Univ Münster–Danaher: mass spectrometer, 201401 supply existent use of AB Sciex QTRAP 5500 system with MRM by Institute for Food Chemistry 2014-01-28
Univ Münster–Danaher: mass spectrometer, 201401 supply existent use of AB Sciex TripleTOF 5600 system by Institute for Food Chemistry 2014-01-28
Trianta Immunotherapies–Medigene: investment, 201401 acquisition 100% for 1m shares worth €4m plus €5.875m milestones in shares or cash 2014-01-27
TiGenix–PharmaCell: investment, 201401 acquisition €5.75m of Dutch manfucturing plant TiGenix BV from TiGenix NV by PharmaCell BV 2014-01-24
Nestlé–Singapore (govt): foods + beverages, 201401– collab food + nutrition r+d in Singapore with A*STAR research institutes 2014-01-22
ACIB–Ionicon: mass spectrometry, 203101 collab existent Ionicon is a partner an ACIB providing PRT-MS technology 2014-01-21
Axel Semrau–Bruker Corp: GC/MS solutions, 201401– collab configuration + sale of automated GC/MS solutions by Semrau using SCION TQ GC/MS systems 2014-01-21
Piqur Therapeutics–SEVERAL: investment, 201401 financing round Series A private placement to new + existing investors 2014-01-21
Biofrontera–SEVERAL: investment, 201401–201402 capital increase €15.3m net with 4.4m news shares 2014-01-20
BPCE–SEVERAL: investment, 201401 launch €120m Seventure Health for Life Capital Fund incl investors Danone + Tereos + Tornier + Natixis + Unigrains 2014-01-20
Qiagen–Trinean: UV/VIS spectrophotometer, 201401– OEM manufacture + supply ww of QIAxpert system by Trinean 2014-01-18
4-Antibody–Agenus: investment, 201401–201402 acquisition $10m in 3.3m shares plus milestones that may exceed $40m in cash or shares 2014-01-13
Boehringer–Argen-X: SIMPLE antibody discovery platform, 201401– collab €na pilot research agreement 2014-01-13
Merck (DE)–KineMed: biomarker discovery services, 201401– supply service applying mass spec to identify protein + lipid multiple sclerose markers 2014-01-13
Recepta Biopharma–4-Antibody: Retrocyte Display technology, 201401 collab existent 2014-01-13
Molecular Health–GATC Biotech: DNA sequencing, 201401– supply protocols + support + training + LIMS to Molecular Health Inc 2014-01-10
Probi–Symrise: investment, 201401– mandatory offering SEK40.1/share for all remaining shares of Probi AB after increase of Symrise holdings to 30.03% 2014-01-10
AC Immune–SEVERAL: investment, 201401 financing round Series D CHF20m from existent private investors 2014-01-09
Aravis–College Group: public relations, 201401 service existent by College Hill Life Sciences 2014-01-09
Gen Ilac–Apeiron: APN311, 201401– license €na excl rights to market + sell APN311 in Turkey 2014-01-09
Index Ventures–Lonza: biologicals contract manufacturing, 201401– service 5y developm + manufacture of biologics for portfolio firms of Index Ventures 2014-01-09
Medison Pharma–Apeiron: APN311, 201401– license €na excl rights to market + sell APN311 in Israel 2014-01-09
Merck (DE)–Eurofins: investment, 201401 acquisition of Merck Millipore DDS business by Eurofins 2014-01-09
Roche–Santaris Pharma: LNA technology, 201401– collab $10m upfront + $138m milestones + royalties ww discovery + developm of RNA-targeted medicines 2014-01-09
next pagenext page 1 2 3 ... 27 28 29 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top